Abstract

Tuberculosis (TB) is of one the most infectious disease caused by Mycobacterium tuberculosis which remains a serious public health problem. Emergence of multi-drug resistant strains of M. tuberculosis led to development of new and more potent anti-tuberculosis agents. The aim of this study was to correlate the chemical structures of the inhibitory compounds with their experimental activities. In this study, analogs of 2,4-disubstituted quinoline derivatives as potent anti-tubercular agents was subjected to quantitative structure–activity relationship (QSAR) analysis in order to build a QSAR model for predicting the activities of these compounds. In order to build the regression model, Genetic Function Approximation (GFA) and Multi-linear Regression approach were used to predict the activities of inhibitory compounds. Based on the prediction, the best validation model was found to have squared correlation coefficient (R2) of 0.9367, adjusted squared correlation coefficient (R2 adj) value of 0.9223 and cross validation coefficient (Qcv2) value of 0.8752. The chosen model was subjected to external validations and the model was found to have (R2 test) of 0.8215 and Y-randomization Coefficient (cRp2) of 0.6633. The proposed QSAR model provides a valuable approach for designing more potent anti-tubercular agents.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call